Skip to content

Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses

Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02815735
Enrollment
85
Registered
2016-06-28
Start date
2016-08-31
Completion date
2017-02-28
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The aim of this study is to compare the subjective performance of the comfilcon A contact lens against lotrafilcon B contact lens after 4 weeks of reusable lens wear.

Detailed description

This will be a 80 subject, randomized, bilateral, double-masked, dispensing, cross-over study comparing comfilcon A versus lotrafilcon B lenses over 4 weeks of daily wear for each lens pair.

Interventions

DEVICEcomfilcon A

contact lens

contact lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 34 Years
Healthy volunteers
Yes

Inclusion criteria

* Spherical distance CL (Contact Lens) prescription between -1.00 and -6.00D (Diopter) OR in both eyes (inclusive) * Adapted soft CL wearers (i.e. \>1 month) who are reusable lens wearers\* * Spectacle cylinder 0.75D in both eyes * Correctable to 6/9 in both eyes * Be between 18 and 34 years of age (inclusive) * Able to read, comprehend and sign an informed consent * Own a mobile phone and be able to respond to SMS survey during the period 8am - 8pm * Willing to comply with the wear and study visit schedule

Exclusion criteria

Any of the following will render a subject ineligible for inclusion: * Existing wearer of daily disposable contact lenses * Known allergy to Opti-Free PureMoist multipurpose solution * Any active corneal infection, injury or inflammation * Systemic or ocular allergies, which might interfere with CL wear * Systemic disease, which might interfere with CL wear * Ocular disease, which might interfere with CL wear * Strabismus or amblyopia * Subjects who have undergone corneal refractive surgery * Subjects with keratoconus or other severe corneal irregularity contraindicating lens wear * Pregnant, planning a pregnancy or lactating * Use of systemic/topical medication contraindicating CL wear * Diabetic * Site employees or family members of investigators * Participation in any concurrent trial or in the last 30 days

Design outcomes

Primary

MeasureTime frameDescription
ComfortBaseline, 2 weeks, 4 weeksComfort (insertion, end of the day, and overall) for habitual lenses assessed at baseline and comfilcon A and lotrafilcon B lenses assessed at 2 weeks and 4 weeks. Scale 0-10, 0=painful, 10=can't feel the lenses.
Comfort During the DayDays 3, 12, 26Comfort during the day for comfilcon A and lotrafilcon B lenses assessed via via SMS (short message service) text message at days 3,12, and 26 at hours 8:00 am, 12:00 pm, 4:00 pm, and 8:00 pm. Scale 0-10, 0=painful, 10=can't feel the lenses.

Countries

United Kingdom

Participant flow

Pre-assignment details

Four subjects were not dispensed lenses due to screen failure. Seven subjects discontinued from the study due to the investigational site withdrawing from the study.

Participants by arm

ArmCount
Overall Participants
Participants wear comfilcon A and lotrafilcon B lens for 4 weeks during the cross over study. comfilcon A: contact lens lotrafilcon B: contact lens
74
Total74

Withdrawals & dropouts

PeriodReasonFG000FG001
First Intervention (4 Weeks)Discomfort10
First Intervention (4 Weeks)Lost to Follow-up10
First Intervention (4 Weeks)Poor fitting characteristics01
Second Intervention (4 Weeks)Protocol Violation10

Baseline characteristics

CharacteristicOverall Participants
Age, Continuous26.5 years
STANDARD_DEVIATION 4.5
Sex: Female, Male
Female
51 Participants
Sex: Female, Male
Male
23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 740 / 74
other
Total, other adverse events
0 / 740 / 74
serious
Total, serious adverse events
0 / 740 / 74

Outcome results

Primary

Comfort

Comfort (insertion, end of the day, and overall) for habitual lenses assessed at baseline and comfilcon A and lotrafilcon B lenses assessed at 2 weeks and 4 weeks. Scale 0-10, 0=painful, 10=can't feel the lenses.

Time frame: Baseline, 2 weeks, 4 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Habitual (Baseline)ComfortOverall comfort8.86 units on a scaleStandard Deviation 1.38
Habitual (Baseline)ComfortComfort on insertion8.90 units on a scaleStandard Deviation 1.38
Habitual (Baseline)ComfortEnd-of-Day Comfort8.03 units on a scaleStandard Deviation 1.78
Comfilcon A (2 Weeks)ComfortComfort on insertion9.03 units on a scaleStandard Deviation 1.1
Comfilcon A (2 Weeks)ComfortEnd-of-Day Comfort7.31 units on a scaleStandard Deviation 2.21
Comfilcon A (2 Weeks)ComfortOverall comfort8.13 units on a scaleStandard Deviation 1.69
Lotrafilcon B (2 Weeks)ComfortComfort on insertion8.70 units on a scaleStandard Deviation 1.57
Lotrafilcon B (2 Weeks)ComfortOverall comfort8.43 units on a scaleStandard Deviation 1.54
Lotrafilcon B (2 Weeks)ComfortEnd-of-Day Comfort7.45 units on a scaleStandard Deviation 2.23
Comfilcon A (4 Weeks)ComfortEnd-of-Day Comfort7.23 units on a scaleStandard Deviation 2.17
Comfilcon A (4 Weeks)ComfortComfort on insertion8.74 units on a scaleStandard Deviation 1.25
Comfilcon A (4 Weeks)ComfortOverall comfort8.11 units on a scaleStandard Deviation 1.57
Lotrafilcon B (4 Weeks)ComfortOverall comfort8.24 units on a scaleStandard Deviation 1.65
Lotrafilcon B (4 Weeks)ComfortComfort on insertion8.60 units on a scaleStandard Deviation 1.62
Lotrafilcon B (4 Weeks)ComfortEnd-of-Day Comfort7.34 units on a scaleStandard Deviation 2.34
Primary

Comfort During the Day

Comfort during the day for comfilcon A and lotrafilcon B lenses assessed via via SMS (short message service) text message at days 3,12, and 26 at hours 8:00 am, 12:00 pm, 4:00 pm, and 8:00 pm. Scale 0-10, 0=painful, 10=can't feel the lenses.

Time frame: Days 3, 12, 26

Population: Missing data from one participant.

ArmMeasureGroupValue (MEAN)Dispersion
Habitual (Baseline)Comfort During the Day4:00 pm8.51 units on a scaleStandard Deviation 1.58
Habitual (Baseline)Comfort During the Day12:00 pm8.94 units on a scaleStandard Deviation 1.48
Habitual (Baseline)Comfort During the Day8:00 pm8.15 units on a scaleStandard Deviation 1.94
Habitual (Baseline)Comfort During the Day8:00 am8.98 units on a scaleStandard Deviation 1.34
Comfilcon A (2 Weeks)Comfort During the Day12:00 pm8.95 units on a scaleStandard Deviation 1.22
Comfilcon A (2 Weeks)Comfort During the Day8:00 pm8.14 units on a scaleStandard Deviation 1.59
Comfilcon A (2 Weeks)Comfort During the Day8:00 am8.78 units on a scaleStandard Deviation 1.6
Comfilcon A (2 Weeks)Comfort During the Day4:00 pm8.74 units on a scaleStandard Deviation 1.31
Lotrafilcon B (2 Weeks)Comfort During the Day8:00 am8.67 units on a scaleStandard Deviation 1.21
Lotrafilcon B (2 Weeks)Comfort During the Day4:00 pm8.51 units on a scaleStandard Deviation 1.49
Lotrafilcon B (2 Weeks)Comfort During the Day8:00 pm7.91 units on a scaleStandard Deviation 1.89
Lotrafilcon B (2 Weeks)Comfort During the Day12:00 pm8.59 units on a scaleStandard Deviation 1.26
Comfilcon A (4 Weeks)Comfort During the Day4:00 pm8.70 units on a scaleStandard Deviation 1.45
Comfilcon A (4 Weeks)Comfort During the Day8:00 am8.96 units on a scaleStandard Deviation 1.26
Comfilcon A (4 Weeks)Comfort During the Day12:00 pm8.73 units on a scaleStandard Deviation 1.41
Comfilcon A (4 Weeks)Comfort During the Day8:00 pm8.25 units on a scaleStandard Deviation 1.77
Lotrafilcon B (4 Weeks)Comfort During the Day12:00 pm8.72 units on a scaleStandard Deviation 1.39
Lotrafilcon B (4 Weeks)Comfort During the Day4:00 pm8.31 units on a scaleStandard Deviation 1.56
Lotrafilcon B (4 Weeks)Comfort During the Day8:00 am8.78 units on a scaleStandard Deviation 1
Lotrafilcon B (4 Weeks)Comfort During the Day8:00 pm7.85 units on a scaleStandard Deviation 1.7
Lotrafilcon B (Day 26)Comfort During the Day12:00 pm8.60 units on a scaleStandard Deviation 1.32
Lotrafilcon B (Day 26)Comfort During the Day8:00 pm7.89 units on a scaleStandard Deviation 1.92
Lotrafilcon B (Day 26)Comfort During the Day4:00 pm8.27 units on a scaleStandard Deviation 1.62
Lotrafilcon B (Day 26)Comfort During the Day8:00 am8.59 units on a scaleStandard Deviation 1.48

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026